Varaico: Literature-Extracted Genetic Variants

Gene:ARSB
Variant:p.G137V
Back to variants list

ARSB

NM_000046.5:p.G137V

Associated Papers

Elucidating the functional impact of G137V and G144R variants in Maroteaux Lamy's Syndrome by Molecular Dynamics Simulation.

Madhana Priya N et al.

Molecular Diversity, 2024

Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene.

Tomanin R et al.

Human Mutation, 2018

30118150 (PubMed )
Supplement: HUMU-39-1788-s001.pdf

Mucopolysaccharidosis VI.

Valayannopoulos V et al.

Orphanet Journal of Rare Diseases, 2010

Structural and clinical implications of amino acid substitutions in N-acetylgalactosamine-4-sulfatase: insight into mucopolysaccharidosis type VI.

Saito S et al.

Molecular Genetics and Metabolism, 2008

Loss of protein structure stability as a major causative factor in monogenic disease.

Yue P et al.

Journal of Molecular Biology, 2005

Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.

Litjens T et al.

Human Mutation, 2001

Maroteaux-lamy syndrome: five novel mutations and their structural localization.

Villani GR et al.

Biochimica Et Biophysica Acta, 1999

Biochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctata.

Daniele A et al.

American Journal of Human Genetics, 1998

Structure of a human lysosomal sulfatase.

Bond CS et al.

Structure (london, England : 1993), 1997

Juvenile form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). A C-terminal extension causes instability but increases catalytic efficiency of arylsulfatase B.

Arlt G et al.

The Journal of Biological Chemistry, 1994

Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity.

Jin WD et al.

American Journal of Human Genetics, 1992

Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.

Wicker G et al.

The Journal of Biological Chemistry, 1991

Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients.

Brooks DA et al.

American Journal of Human Genetics, 1991

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."